Turkish Version of Pain Modulation Index
Reliability and Validity of the Turkish Version of the Pain Modulation Index
1 other identifier
observational
125
1 country
1
Brief Summary
In order to assess the validity and reliability of the Turkish version of Pain Modulation Index, 125 volunteers with chronic pain were enrolled in the study. Test and re-test method was used to assess reliability and correlation analyses with Pain Detect, visual analog scale pain and central sensitization inventory scores were used to assess validity of the questionnaire. Turkish version of the Pain Modulation Index was found to be a valid and reliable tool for evaluating chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2023
CompletedFirst Submitted
Initial submission to the registry
January 16, 2023
CompletedFirst Posted
Study publicly available on registry
January 26, 2023
CompletedJanuary 26, 2023
January 1, 2023
7 months
January 16, 2023
January 16, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Reliability of the Turkish version of pain modulation index
Internal consistency was evaluated by test retest method and calculating the coefficient alpha (α) or Cronbach's coefficient, and if the Cronbach's coefficient value was greater than 0.7, it was considered as an acceptable internal consistency
15 days
Validity of the Turkish version of Pain Modulation Index
Index scores were analysed for their correlation with Pain Detect and Central Sensitization Inventory scores.
1 day
Study Arms (1)
Patients with chronic pain
Patients with non-cancer pain of more than 3 months duration.
Interventions
A 18 item questionnaire assessing patients' pain characteristics for the detection of disordered pain modulation processes.
A questionnaire that was validated for the assessment of neuropathic pain
A questionnaire developed for the detection of central sensitization.
Eligibility Criteria
Patients who had non-cancer pain for more than 3 months duration.
You may qualify if:
- presence of chronic non-cancer pain of more than 3 months duration
You may not qualify if:
- Illiteracy
- Refusal to take part in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University Hospital, Department of Physical and rehabilitation medicine
Bornova, İzmir, 355100, Turkey (Türkiye)
Related Publications (1)
Austin PD, Asghari A, Costa DSJ, Siddall PJ. The development of a novel questionnaire assessing alterations in central pain processing in people with and without chronic pain. Scand J Pain. 2020 Apr 28;20(2):407-417. doi: 10.1515/sjpain-2019-0087.
PMID: 31785195BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simin Hepguler, Prof
Ege University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 16, 2023
First Posted
January 26, 2023
Study Start
February 1, 2022
Primary Completion
September 1, 2022
Study Completion
January 5, 2023
Last Updated
January 26, 2023
Record last verified: 2023-01